1. Fish Oil Enriched Intravenous Lipid Emulsions Reduce Triglyceride Levels in Non-Critically Ill Patients with TPN and Type 2 Diabetes. A Post-Hoc Analysis of the INSUPAR Study.
- Author
-
Abuín-Fernández J, Tapia-Guerrero MJ, López-Urdiales R, Herranz-Antolín S, García-Almeida JM, García-Malpartida K, Ferrer-Gómez M, Cancer-Minchot E, Luengo-Pérez LM, Álvarez-Hernández J, Valera CA, Ocón-Bretón J, García-Manzanares Á, Bretón-Lesmes I, Serrano-Aguayo P, Pérez-Ferre N, López-Gómez JJ, Olivares-Alcolea J, Arraiza-Irigoyen C, Tejera-Pérez C, Martínez-González JD, Urioste-Fondo A, Abad-González ÁL, Molina-Puerta MJ, Zugasti-Murillo A, Parra-Barona J, López-Cobo I, and Olveira-Fuster AG
- Subjects
- Aged, Aged, 80 and over, Blood Glucose, Fatty Acids, Omega-3 therapeutic use, Female, Humans, Hypoglycemic Agents, Insulin, Liver metabolism, Male, Middle Aged, Parenteral Nutrition, Triglycerides blood, Diabetes Mellitus, Type 2 drug therapy, Fat Emulsions, Intravenous therapeutic use, Fish Oils therapeutic use, Parenteral Nutrition, Total adverse effects, Triglycerides metabolism
- Abstract
There are no studies that have specifically assessed the role of intravenous lipid emulsions (ILE) enriched with fish oil in people with diabetes receiving total parenteral nutrition (TPN). The objective of this study was to assess the metabolic control (glycemic and lipid) and in-hospital complications that occurred in non-critically ill inpatients with TPN and type 2 diabetes with regard to the use of fish oil emulsions compared with other ILEs. We performed a post-hoc analysis of the Insulin in Parenteral Nutrition (INSUPAR) trial that included patients who started with TPN for any cause and that would predictably continue with TPN for at least five days. The study included 161 patients who started with TPN for any cause. There were 80 patients (49.7%) on fish oil enriched ILEs and 81 patients (50.3%) on other ILEs. We found significant decreases in triglyceride levels in the fish oil group compared to the other patients. We did not find any differences in glucose metabolic control: mean capillary glucose, glycemic variability, and insulin dose, except in the number of mild hypoglycemic events that was significantly higher in the fish oil group. We did not observe any differences in other metabolic, liver or infectious complications, in-hospital length of stay or mortality., Competing Interests: The authors have no multiplicity of interest to disclose.
- Published
- 2020
- Full Text
- View/download PDF